Overview

The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The purpose of the trial is to assess the effect of liraglutide on forearm blood flow in subjects with type 2 diabetes who are on diet and lifestyle changes or treated with metformin alone.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glimepiride
Liraglutide